GM-CSF Recombinant Human Protein
Product Image
Gibco™

GM-CSF Recombinant Human Protein

Recombinant GM-CSF is a bioactive protein intended for use in cell culture applications. Recombinant human GM-CSF is intended for useMás información
Have Questions?
Número de catálogoCantidad
CTP2011100 μg
Número de catálogo CTP2011
Precio (MXN)
-
Cantidad:
100 μg
Recombinant GM-CSF is a bioactive protein intended for use in cell culture applications. Recombinant human GM-CSF is intended for use in cell culture applications. GM-CSF is involved in many biological responses including the growth and development of granulocyte and macrophage progenitor cells, stimulation and the initiation of differentiation of myeloblasts and monoblasts, and chemotaxis of eosinophils. ED50 range = 0.02 to 0.1 ng⁄mL, determined by the dose dependent proliferation of human TF-1 cells. Optimal concentration for individual application should be determined by a dose response assay.
For Research Use Only. Not for use in diagnostic procedures.
Especificaciones
Actividad0.055 ng/ml
BioensayoProliferation of TF1 cells
ClasificaciónCarrier-Free
Nivel de endotoxinas<0.1 ng/μg
Sistema de expresiónE. coli
Alias de genGM-CSF
Peso molecular14 kDa
Línea de productosGibco
Familia de proteínasCytokines & Receptors
Forma de proteínaFull Length, Recombinant, Ligand
Subtipo de proteínaGM-CSF, G-CSF, & M-CSF
Método de purificaciónGel-Purified
Grado de pureza o calidad95 %
Cantidad100 μg
ReactividadHuman
Categoría de investigaciónClinical Research, Oncology, Stem Cell Research, Differentiation, Signal Transduction, Drug Development
Condiciones de envíoWet Ice
FuenteHuman
Para utilizar con (aplicación)Cell Culture
RecombinanteRecombinant
EspecieHuman
Unit Size100 µg
Contenido y almacenamiento
Lyophilized protein can be stored at 2°C to 8°C dessicated. Once reconstituted, store in aliquots at ≤20°C. Avoid multiple freeze⁄thaw cycles.

Preguntas frecuentes

It looks like the recombinant protein vial I received from you is empty. Is this normal?

Gibco recombinant proteins are frequently formulated without carrier proteins or additives (e.g., BSA, HSA, sucrose, etc.) and no Gibco PeproTech recombinant protein contains a carrier protein. As a result, during lyophilization, the protein product may be deposited on the vial as a thin, and sometimes invisible, film instead of a pellet. The size of the pellet, if any, is not directly related to the quantity of the recombinant protein in the vial. Our quality control procedures assure that each vial contains the correct amount of product.

To ensure complete recovery of protein product, before opening a vial of lyophilized recombinant protein, we recommend centrifuging it in a microcentrifuge for 20-30 seconds to drive any protein that may be lodged in the cap or on the side to the bottom of the vial. After reconstitution, you can confirm the presence of product protein by running a small amount on SDS-PAGE. In general, a protein band with expected size should be visible with as little as 10 ng of protein loaded on an acrylamide gel.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Why does my recombinant protein not show activity in my own experiment?

Assay time is critical. Each assay needs to beoptimized and performed at the peak response time. Different cells may respond differently to a growth factor or cytokine. We suggest repeating our QC assay using same indicator cells as suggested in the manual to see if you can obtain a similar response. In addition, serum may be masking the response. Serum starvation might be needed for certain types of assays.

How should I store the reconstituted recombinant proteins?

Protein solutions are generally not very stable when frozen at low concentration. Upon freeze and thaw, some proteins in the solution may stick to the wall of the container, which results in significant reduction of protein concentration if the starting concentration was low. Therefore, carrier proteins are used to reduce such loss. The most commonly used carrier proteins include bovine serum albumin (BSA), human serum albumin (HSA), or fetal bovine serum (FBS). These carrier proteins are generally used at 0.1% concentration. As a rule of thumb, if the concentration of the recombinant protein is less than 0.5 mg/mL, it is a good idea to add some carrier protein

How do I store my lyophilized recombinant protein?

Lyophilized proteins can typically be stored at 2 to 8 degrees C for several weeks, or stored dessicated at -20 degrees C for long-term storage.

Citations & References (7)

Citations & References
Abstract
SOCS2 influences LPS induced human monocyte-derived dendritic cell maturation.
Authors:Hu J, Winqvist O, Flores-Morales A, Wikström AC, Norstedt G
Journal:PLoS One
PubMed ID:19779605
'Dendritic cells (DCs) are highly specific antigen presenting cells, which link innate and adaptive immune responses and participate in protecting hosts from invading pathogens. DCs can be generated in vitro by culturing human monocytes with GM-CSF and IL-4 followed by LPS induced DC maturation. We set out to study the ... More
Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.
Authors:St-Amour I, Laroche A, Bazin R, Lemieux R
Journal:Clin Immunol
PubMed ID:19604724
'The mechanisms of therapeutic action of IVIg are still unclear in most autoimmune and inflammatory diseases. IVIg have been shown to bind to a variety of human proteins including BAFF, amyloid beta peptide and GM-CSF. It has been suggested that this autoreactivity could contribute to the therapeutic immunomodulatory effects of ... More
Lentiviral vector transduction of dendritic cells for novel vaccine strategies.
Authors:Chang LJ
Journal:Methods Mol Biol
PubMed ID:20225043
'Dendritic cells (DCs) are key antigen-presenting cells that induce primary and memory immune response. Patients with chronic infections or cancer often display DC dysfunctions. Modification of DCs or DC progenitors in vitro may overcome the problems with defective DCs in vivo. Lentiviral vector is highly efficient in transducing hematopoietic cells ... More
LPS regulates SOCS2 transcription in a type I interferon dependent autocrine-paracrine loop.
Authors:Hu J, Lou D, Carow B, Winerdal ME, Rottenberg M, Wikström AC, Norstedt G, Winqvist O
Journal:PLoS One
PubMed ID:22291912
'Recent studies suggest that SOCS2 is involved in the regulation of TLR signaling. In this study, we found that the expression of SOCS2 is regulated in human monocyte-derived DC by ligands stimulating TLR2, 3, 4, 5, 8 and 9 signaling. SOCS2 induction by LPS was dependent on the type I ... More
In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy.
Authors:van Kooten C, Gelderman KA
Journal:Methods Mol Biol
PubMed ID:20941608
Dendritic cells (DCs) have a central role in immune regulation and serve as an essential link between innate and adaptive immunity. Their broad range of powerful immune stimulatory as well as regulatory functions has made DCs a target for vaccine development strategies. One approach to promote the tolerogenicity of DCs ... More